3 Key Takeaways
Plain English Summary- 01Core Finding
Body weight increased by +5 kg (interquartile range 4-7.75; P = 0.006), as did serum albumin (+8 g/L; P = 0.006).
- 02Study Evidence
Tested in a observational cohort study (11 participants) at the real-world cohort stage.
- 03Practical Meaning
Observational cohort findings reveal real-world links, though lifestyle or unmeasured factors cannot be fully ruled out without an RCT.
What This Means for You
CGMS-guided insulin optimization was associated with improvements in glucose control and nutritional status.
Published in Diabetes care, these peer-reviewed endocrinology findings provide quantitative clinical evidence to inform risk stratification, therapeutic decision-making, and follow-up validation.
The Discovery
To evaluate whether a continuous glucose monitoring (CGM) system (CGMS)-guided insulin optimization can improve glucose control and nutritional status in insulin-treated patients receiving long-term nocturnal parenteral nutrition (PN). Glucose profiles improved after the intervention: less time >250 mg/dL (a clinically meaningful level to a clinically meaningful level; -139 ± 113 min/day; P = 0.02), more time in range (a clinically meaningful level to a clinically meaningful level; +206 ± 118 min/day; P = 0.002), and without more hypoglycemia. HbA1c decreased by -a clinically meaningful level (-8 mmol/mol; P = 0.04), and glycosuria resolved in all affected patients (P = 0.03). Body weight increased by +5 kg (interquartile range 4-7.75; P = 0.006), as did serum albumin (+8 g/L; P = 0.006). Malnutrition resolved among 8 of 11 participants (P < 0.05).
How It Works, Simply
This endocrinology research focuses on insulin. Researchers evaluated it using an observational cohort study (11 participants) at the real-world cohort stage of medical research.
3 Key Takeaways
Clinical Takeaways- 01Core Finding
Body weight increased by +5 kg (interquartile range 4-7.75; P = 0.006), as did serum albumin (+8 g/L; P = 0.006).
- 02Study Evidence
Tested in a observational cohort study (11 participants) at the real-world cohort stage.
- 03Practical Meaning
Observational cohort findings reveal real-world links, though lifestyle or unmeasured factors cannot be fully ruled out without an RCT.
Biological Mechanism & Study Design
Study Design & Cohort
Observational cohort study
Observational cohort study (11 participants) · Real-World Cohort
Biological Pathway & Modality
Insulin
Intervention: Continuous Glucose Monitoring-Guided Insulin Optimization in Patients Receiving
Experimental Findings & Endpoints
To evaluate whether a continuous glucose monitoring (CGM) system (CGMS)-guided insulin optimization can improve glucose control and nutritional status in insulin-treated patients receiving long-term nocturnal parenteral nutrition (PN).
Glucose profiles improved after the intervention: less time >250 mg/dL (a clinically meaningful level to a clinically meaningful level; -139 ± 113 min/day; P = 0.02), more time in range (a clinically meaningful level to a clinically meaningful level; +206 ± 118 min/day; P = 0.002), and without more hypoglycemia. HbA1c decreased by -a clinically meaningful level (-8 mmol/mol; P = 0.04), and glycosuria resolved in all affected patients (P = 0.03).
Body weight increased by +5 kg (interquartile range 4-7.75; P = 0.006), as did serum albumin (+8 g/L; P = 0.006). Malnutrition resolved among 8 of 11 participants (P < 0.05).
Clinical Translation & Practice Context
CGMS-guided insulin optimization was associated with improvements in glucose control and nutritional status.
Published in Diabetes care, these peer-reviewed endocrinology findings provide quantitative clinical evidence to inform risk stratification, therapeutic decision-making, and follow-up validation.
The Bottom Line · Clinical Pearl
“CGMS-guided insulin optimization was associated with improvements in glucose control and nutritional status.”
Published in Diabetes Care · Current Stage: Real-World Cohort